Recently, it has been reported that Nrf2 activation protects diabetic EPCs against the effects of oxidative stress and cell senescence, ameliorating the biological dysfunction of EPCs derived from mice with diabetes [74]. Here, NFE2L2 is linked to diabetes mellitus.